SB03
External Genital Warts
ApprovedActive
Key Facts
About SynCore Biotechnology
Taiwan‑based public biotech advancing oncology, ophthalmology and dermatology pipelines with Phase‑3 assets.
View full company profileTherapeutic Areas
Other External Genital Warts Drugs
| Drug | Company | Phase |
|---|---|---|
| VP-102 | Verrica Pharmaceuticals | Phase 2 |